類器官Y-27632 dihydrochloride
| 參考價 | ￥3750.00 |
- 公司名稱 普邁精醫科技（北京）有限公司
- 品牌其他品牌
- 型號
- 所在地北京市
- 廠商性質代理商
- 更新時間2025/6/26 10:47:49
- 訪問次數 909
| 50mg | 3750.00元 | 50 mg可售 |
聯系方式：林明400-609-0003 查看聯系方式
聯系我們時請說明是化工儀器網上看到的信息，謝謝!
| 供貨周期 | 現貨 |
|---|
類器官Y-27632 dihydrochloride
類器官（Organoids）是指將成體干細胞或多能干細胞在體外三維培養形成的具有一定空間結構的組織類似物。類器官在組織結構、細胞類型、自我更新能力和功能等方面與來源組織高度一致，從而在發育生物學、疾病造模、精準醫學、藥物研發、基因和細胞療法、感染和免疫以及再生醫學等生物醫學的多個領域展現出*的優勢。
產品介紹DESCRIPTION
| Background | Y-27632 dihydrochloride is an orally active, ATP-competitive inhibitor of ROCK-I and ROCK-II, with Kis of 220 and 300 nM, respectively. Y-27632 dihydrochloride attenuates Doxorubicin-induced apoptosis of human cardiac stem cells. Y-27632 also suppresses dissociation-induced apoptosis of murine prostate stem/progenitor cells. Y-27632 dihydrochloride primes human induced pluripotent stem cells (hIPSCs) to selectively differentiate towards mesendodermal lineage via epithelial-mesenchymal transition-like modulation[1][2][3][4][5]. |
技術參數
| M. W t | 320.26 | ||
| Formula | C14H23Cl2N3O | ||
| CAS No | 129830-38-2 | ||
| Storage | Powder | -20 °C | 3 years |
| In solvent | -80°C | 6 months | |
| -20 °C | 1 month | ||
| Solubility | DMSO | 33.33 mg/mL(104.07 mM; Need ultrasonic) | |
| H2O | 100 mg/mL(312.25 mM; Need ultrasonic) | ||
BIOLOGICAL ALTIVITY
In Vitro
Y-27632 inhibits the ROCK family of kinases 100 times more potently than other kinases including protein kinase C, cAMP-dependent kinase and myosin light chain kinase. Y-27632 prolongs the lag time and delays the appearance of BrdU-labeled cells in a concentration-dependent manner, delays of about 1 and 4 h are noticed in the Swiss 3T3 cells treated with 10 and 100 μM Y-27632, respectively[1].
Y-27632 promotes neuronal differentiation of adipose tissue-derived stem cells (ADSCs). Compared to 1.0 and 2.5 μM Y-27632 induced groups, percentages of neuroal-like cells achieved a peak in the 5.0 μM Y-27632 induced group[2].
In Vivo
Y-27632 (5 and 10 mg/kg) significantly prolongs the onset time of myoclonic jerks when compare with saline group. Y-27632 (5 and 10 mg/kg) significantly prolongs the onset time of clonic convulsions when compare with saline group[3].
Treatment with Dimethylnitrosamine (DMN) causes a significant decrease in rat body and liver weight (DMN-S group) compared with control animals (S-S group). Oral Y27632 (30 mg/kg) essentially prevents this DMN-induced rat body and liver weight loss (DMN-Y group)[4].
類器官Y-27632 dihydrochloride
采購中心
化工儀器網